0001600132-18-000179.txt : 20181123 0001600132-18-000179.hdr.sgml : 20181123 20181123162438 ACCESSION NUMBER: 0001600132-18-000179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181120 FILED AS OF DATE: 20181123 DATE AS OF CHANGE: 20181123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tenenbaum Fabian CENTRAL INDEX KEY: 0001641300 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 181199730 MAIL ADDRESS: STREET 1: 60 EAST 42ND STREET, SUITE 1160 CITY: NEW YORK STATE: NY ZIP: 10165 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 wf-form4_154300826116009.xml FORM 4 X0306 4 2018-11-20 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001641300 Tenenbaum Fabian 184 LIBERTY CORNER ROAD SUITE 302 WARREN NJ 07059 0 1 0 0 Chief Executive Officer Stock Option (right to buy) 0.91 2018-11-20 4 A 0 1487500 0 A 2028-11-20 Common Stock 1487500.0 3676197 D This option was granted on November 20, 2018. This option vests in quarterly installments over a four-years period from the date of grant. /s/ Fabian Tenenbaum 2018-11-20